X Financial FY2025 presentation: strong metrics mask Q4 challenges

Q4 net income plunged 96.2% y/y to $8.2M and the stock fell ~11.28% premarket to $4.099. Full-year results show net income $209M, revenue $1.09B (+30.1% y/y), ROE 19.8%, ROA 11.1%, EPS $5.15, ~6.7M active borrowers and ~$247M net cash, while trading at ~0.2x book with a market cap of ~$219M and a ~9.5% dividend yield; $46M remains in a $100M buyback. Management cited conservative fourth-quarter credit provisioning and regulatory uncertainty in China (no quantitative 2026 guidance); delinquency rates were 31-60 days 2.90% and 91-180 days 6.31%, implying material near-term risk despite attractive valuation and capital returns.

Analysis

The market is treating regulatory uncertainty as a structural impairment rather than a temporary shock, which creates a time arbitrage for patient, event-driven capital. Management’s liquidity-first posture materially lengthens the runway for shareholder-friendly actions (buybacks/dividends) but also raises the probability of growth-forgive strategies that preserve access to institutional funding rather than lean into volume.

A key second-order effect is funding-fragmentation: if institutional partners tighten underwriting or demand larger credit enhancement, margin waterfall dynamics will reprice away from platform fees toward higher spread for capital providers — benefitting large, regulated banks and trust companies that can demand premium returns. Conversely, non-bank fintechs and any channel where the platform retains balance-sheet credit risk are the natural losers if wholesale terming deteriorates.

Catalysts cluster on a 1–12 month axis: near-term price moves will reflect regulatory clarifications and provincial implementation notes, while a sustained rerating requires restoration of predictable institutional funding flows. Tail risk remains a sudden withdrawal of third-party funding or a punitive policy action that forces immediate deleveraging; the reverse — explicit regulatory guidance restoring normal co-lending mechanics — would likely compress implied equity risk premia quickly.

The clearest mispricing here is one of probability, not math: the market seems to price a permanent structural loss of the platform model rather than a scenario where earnings temporarily sag while cash returns and buybacks preserve intrinsic value. That asymmetry creates a tactical opportunity to own the idiosyncratic exposure with tight protection and to express relative value against broader China fintech beta.

Key Decisions for Investors

• Long XYF equity (1–2% NAV): build as a staggered entry on post-earnings volatility and hold 6–12 months. Hedge with a 9–12 month OTM put to cap downside; R/R: asymmetric — limited downside via hedge vs >1.5x upside if funding clarity returns and buyback optionality is realized.
• Option calendar/LEAP structure: buy Jan-2027 XYF calls and finance by selling 3–4 month calls (rolled). Time horizon 12–18 months; reward is high convexity into a positive regulatory outcome, risk is option theta loss — size as a directional satellite (0.5–1% NAV).
• Pair trade (idiosyncratic vs sector): long XYF / short KWEB (equal delta notional), horizon 3–9 months to exploit company-specific recovery vs sector-wide policy risk. This isolates idiosyncratic rerating while limiting exposure to a broad China fintech rally; downside if the entire sector recovers rapidly.